Detalhe da pesquisa
1.
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.
Clin Lymphoma Myeloma Leuk
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431522
2.
Authorship Characteristics of Hematology and Oncology Education Chapters: A Comprehensive Analysis.
J Cancer Policy
; : 100484, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750724
3.
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Bone Marrow Transplant
; 59(5): 647-652, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361116
4.
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
Blood Cancer J
; 14(1): 30, 2024 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355688
5.
Melflufen in multiple myeloma: the conclusion matters.
Lancet Haematol
; 9(4): e244, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358437
6.
Vanishing Lung Syndrome.
J Am Osteopath Assoc
; 117(8): 541, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759097